Coeptis Therapeutics (COEP)

• Market cap: $70.1M
• 1 day: 2.83%
• 5 days: -0.48%
• 1 month: -6.37%
• 3 months: 26.74%
• 6 months: 56.28%
• Year to date: 146.19%
• 1 year: 254.01%
• 5 years: -92.65%
• 10 years: -92.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7